Fan L, Strasser-Weippl K, Li JJ, et al. Breast cancer in China. Lancet Oncol. 2014. 15(7): e279-89.
 Feng RM, Zong YN, Cao SM, Xu RH. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics. Cancer Commun (Lond). 2019. 39(1): 22.
 Li Y, Li Q, Mo H, et al. Incidence, risk factors and survival of patients with brain metastases at initial metastatic breast cancer diagnosis in China. Breast. 2020. 55: 30-36.
 Tan YO, Han S, Lu YS, et al. The prevalence and assessment of ErbB2-positive breast cancer in Asia: a literature survey. Cancer. 2010. 116(23): 5348-57.
 Hasan T, Arora R, Bansal AK, Bhattacharya R, Sharma GS, Singh LR. Disturbed homocysteine metabolism is associated with cancer. Exp Mol Med. 2019. 51(2): 1-13.
 Chen S, Guo X, Dong S, Li Z, Sun Y. Relationship between lifestyle factors and hyperhomocysteinemia in general Chinese population: a cross-sectional study. Postgrad Med. 2017. 129(2): 216-223.
 Song A, Zhao L, Li Y, et al. Haplotypes of the MTHFR gene are associated with an increased risk of breast cancer in a Han Chinese population in Gansu province. IUBMB Life. 2016. 68(7): 526-34.
 Zhang D, Lou J, Zhang X, et al. Hyperhomocysteinemia results from and promotes hepatocellular carcinoma via CYP450 metabolism by CYP2J2 DNA methylation. Oncotarget. 2017. 8(9): 15377-15392.
 Braun DJ, Abner E, Bakshi V, et al. Blood Flow Deficits and Cerebrovascular Changes in a Dietary Model of Hyperhomocysteinemia. ASN Neuro. 2019. 11: 1759091419865788.
 Forges T, Monnier-Barbarino P, Alberto JM, Guéant-Rodriguez RM, Daval JL, Guéant JL. Impact of folate and homocysteine metabolism on human reproductive health. Hum Reprod Update. 2007. 13(3): 225-38.
 McCaddon A. Vitamin B12 in neurology and ageing; clinical and genetic aspects. Biochimie. 2013. 95(5): 1066-76.
 Troen AM, Shea-Budgell M, Shukitt-Hale B, Smith DE, Selhub J, Rosenberg IH. B-vitamin deficiency causes hyperhomocysteinemia and vascular cognitive impairment in mice. Proc Natl Acad Sci U S A. 2008. 105(34): 12474-9.
 Giovannucci E. Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr. 2002. 132(8 Suppl): 2350S-2355S.
 Harnack L, Jacobs DR Jr, Nicodemus K, Lazovich D, Anderson K, Folsom AR. Relationship of folate, vitamin B-6, vitamin B-12, and methionine intake to incidence of colorectal cancers. Nutr Cancer. 2002. 43(2): 152-8.
 Qin T, Du M, Du H, Shu Y, Wang M, Zhu L. Folic acid supplements and colorectal cancer risk: meta-analysis of randomized controlled trials. Sci Rep. 2015. 5: 12044.
 Passarelli MN, Barry EL, Zhang D, et al. Risk of basal cell carcinoma in a randomized clinical trial of aspirin and folic acid for the prevention of colorectal adenomas. Br J Dermatol. 2018. 179(2): 337-344.
 Chandy S, Sadananda Adiga MN, Ramaswamy G, Ramachandra C, Krishnamoorthy L. Effect of Vitamin B(12) and Folate on Homocysteine levels in colorectal cancer. Indian J Clin Biochem. 2008. 23(3): 258-61.
 Sugiyama A, Awaji H, Horie K, Kim M, Nakata R. The beneficial effect of folate-enriched egg on the folate and homocysteine levels in rats fed a folate- and choline-deficient diet. J Food Sci. 2012. 77(12): H268-72.
 Wei Z, Tiandong W, Yang L, et al. Parkinson's Disease and Homocysteine: A Community-Based Study in a Folate and Vitamin B12 Deficient Population. Parkinsons Dis. 2016. 2016: 9539836.
 Meng H, Li Y, Zhang W, Zhao Y, Niu X, Guo J. The relationship between cognitive impairment and homocysteine in a B12 and folate deficient population in China: A cross-sectional study. Medicine (Baltimore). 2019. 98(47): e17970.
 Naushad SM, Reddy CA, Kumaraswami K, et al. Impact of hyperhomocysteinemia on breast cancer initiation and progression: epigenetic perspective. Cell Biochem Biophys. 2014. 68(2): 397-406.
 Varela Almanza KM, Puebla-Pérez AM, Delgado-Saucedo JI, et al. Increased homocysteine plasma levels in breast cancer patients of a Mexican population. Exp Oncol. 2018. 40(2): 114-118.
 Al-Awadi F, Yang M, Tan Y, Han Q, Li S, Hoffman RM. Human tumor growth in nude mice is associated with decreased plasma cysteine and homocysteine. Anticancer Res. 2008. 28(5A): 2541-4.
 Ma Z, Parris AB, Howard EW, et al. Caloric restriction inhibits mammary tumorigenesis in MMTV-ErbB2 transgenic mice through the suppression of ER and ErbB2 pathways and inhibition of epithelial cell stemness in premalignant mammary tissues. Carcinogenesis. 2018. 39(10): 1264-1273.
 Zhao Q, Parris AB, Howard EW, et al. FGFR inhibitor, AZD4547, impedes the stemness of mammary epithelial cells in the premalignant tissues of MMTV-ErbB2 transgenic mice. Sci Rep. 2017. 7(1): 11306.
 Zhang GP, Han D, Liu G, et al. Effects of soy isoflavone and endogenous oestrogen on breast cancer in MMTV-erbB2 transgenic mice. J Int Med Res. 2012. 40(6): 2073-82.
 Ma Z, Kim YM, Howard EW, et al. DMBA promotes ErbB2‑mediated carcinogenesis via ErbB2 and estrogen receptor pathway activation and genomic instability. Oncol Rep. 2018. 40(3): 1632-1640.
 Ma Z, Parris AB, Xiao Z, et al. Short-term early exposure to lapatinib confers lifelong protection from mammary tumor development in MMTV-erbB-2 transgenic mice. J Exp Clin Cancer Res. 2017. 36(1): 6.
 Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987. 235(4785): 177-82.
 Xiao Z, Yang X, Zhang K, et al. Estrogen receptor α/prolactin receptor bilateral crosstalk promotes bromocriptine resistance in prolactinomas. Int J Med Sci. 2020. 17(18): 3174-3189.
 Xiao Z, Liang J, Deng Q, et al. Pimozide augments bromocriptine lethality in prolactinoma cells and in a xenograft model via the STAT5/cyclin D1 and STAT5/Bcl‑xL signaling pathways. Int J Mol Med. 2021. 47(1): 113-124.
 Xiao Z, Yang X, Liu Z, et al. GASC1 promotes glioma progression by enhancing NOTCH1 signaling. Mol Med Rep. 2021. 23(5).
 Ostrom QT, Cote DJ, Ascha M, Kruchko C, Barnholtz-Sloan JS. Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014. JAMA Oncol. 2018. 4(9): 1254-1262.
 DiGiovanna MP, Stern DF, Edgerton SM, Whalen SG, Moore D 2nd, Thor AD. Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patients. J Clin Oncol. 2005. 23(6): 1152-60.
 Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol. 2001. 2(2): 127-37.
 Freudenberg JA, Wang Q, Katsumata M, Drebin J, Nagatomo I, Greene MI. The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies. Exp Mol Pathol. 2009. 87(1): 1-11.
 Ghemrawi R, Pooya S, Lorentz S, et al. Decreased vitamin B12 availability induces ER stress through impaired SIRT1-deacetylation of HSF1. Cell Death Dis. 2013. 4: e553.
 Pooya S, Blaise S, Moreno Garcia M, et al. Methyl donor deficiency impairs fatty acid oxidation through PGC-1α hypomethylation and decreased ER-α, ERR-α, and HNF-4α in the rat liver. J Hepatol. 2012. 57(2): 344-51.
 Burdge GC, Lillycrop KA. Nutrition, epigenetics, and developmental plasticity: implications for understanding human disease. Annu Rev Nutr. 2010. 30: 315-39.
 Vollset SE, Clarke R, Lewington S, et al. Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals. Lancet. 2013. 381(9871): 1029-36.
 Mason JB. Folate, cancer risk, and the Greek god, Proteus: a tale of two chameleons. Nutr Rev. 2009. 67(4): 206-12.
 Guéant JL, Namour F, Guéant-Rodriguez RM, Daval JL. Folate and fetal programming: a play in epigenomics. Trends Endocrinol Metab. 2013. 24(6): 279-89.
 Gallego-Narbón A, Zapatera B, Barrios L, Vaquero MP. Vitamin B12 and folate status in Spanish lacto-ovo vegetarians and vegans. J Nutr Sci. 2019. 8: e7.
 Ronnenberg AG, Goldman MB, Aitken IW, Xu X. Anemia and deficiencies of folate and vitamin B-6 are common and vary with season in Chinese women of childbearing age. J Nutr. 2000. 130(11): 2703-10.
 Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood. 2004. 104(8): 2263-8.
 Ninomiya T, Kiyohara Y, Kubo M, et al. Hyperhomocysteinemia and the development of chronic kidney disease in a general population: the Hisayama study. Am J Kidney Dis. 2004. 44(3): 437-45.
 Mohammad G, Kowluru RA. Homocysteine Disrupts Balance between MMP-9 and Its Tissue Inhibitor in Diabetic Retinopathy: The Role of DNA Methylation. Int J Mol Sci. 2020. 21(5).
 Chen S, Dong Z, Cheng M, et al. Homocysteine exaggerates microglia activation and neuroinflammation through microglia localized STAT3 overactivation following ischemic stroke. J Neuroinflammation. 2017. 14(1): 187.
 Hanley MP, Kadaveru K, Perret C, Giardina C, Rosenberg DW. Dietary Methyl Donor Depletion Suppresses Intestinal Adenoma Development. Cancer Prev Res (Phila). 2016. 9(10): 812-820.
 Figueiredo JC, Mott LA, Giovannucci E, et al. Folic acid and prevention of colorectal adenomas: a combined analysis of randomized clinical trials. Int J Cancer. 2011. 129(1): 192-203.
 Cole BF, Baron JA, Sandler RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA. 2007. 297(21): 2351-9.
 Lin J, Lee IM, Song Y, et al. Plasma homocysteine and cysteine and risk of breast cancer in women. Cancer Res. 2010. 70(6): 2397-405.
 Hynes NE, Lane HA. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer. 2005. 5(5): 341-54.
 Song Q, Chen Y, Wang J, et al. ER stress-induced upregulation of NNMT contributes to alcohol-related fatty liver development. J Hepatol. 2020. 73(4): 783-793.
 Ning H, Sun Z, Liu Y, et al. Insulin Protects Hepatic Lipotoxicity by Regulating ER Stress through the PI3K/Akt/p53 Involved Pathway Independently of Autophagy Inhibition. Nutrients. 2016. 8(4): 227.
 Ma Z, Parris AB, Howard EW, et al. In Utero Exposure to Bisphenol a Promotes Mammary Tumor Risk in MMTV-Erbb2 Transgenic Mice Through the Induction of ER-erbB2 Crosstalk. Int J Mol Sci. 2020. 21(9).